Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis: A Systematic Review and Meta-Analysis

Cardiology in Review
Sahil KheraSrihari S Naidu

Abstract

There are no dedicated data to guide drug-eluting stent (DES) versus bare-metal stent (BMS) selection in patients with end-stage renal disease undergoing dialysis (ESRD-D). It is unclear whether long-term benefits of a specific stent type outweigh risks in this population at high risk for both bleeding and ischemic events. We performed a meta-analysis of nonrandomized studies extracted from PubMed, Scopus, and EMBASE, assessing the safety and effectiveness of DES versus BMS in ESRD-D patients. Odds ratios (OR) and 95% confidence intervals (CI) were computed with the Mantel-Haenszel method. Random-effects model was used for all analyses. A total of 17 nonrandomized studies (N = 63,157; 41,621 DES and 21,536 BMS) met the inclusion criteria and were included for the final quantitative analysis: median follow-up of 1 year (range: 9 months to 6 years). The use of DES in ESRD-D patients was associated with lower all-cause mortality (OR 0.75, 95% CI 0.64-0.89, P < 0.001) compared with BMS. The use of DES was also associated with lower rates of cardiovascular mortality (OR 0.75, 95% CI 0.60-0.99, P = 0.047) and target lesion/vessel revascularization (OR 0.78, 95% CI 0.64-0.94, P = 0.01). However, there were no differences in noncardiov...Continue Reading

References

Mar 28, 1974·The New England Journal of Medicine·A LindnerB H Scribner
Nov 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R N FoleyM J Sarnak
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Peter StenvinkelBengt Lindholm
Aug 26, 2003·Journal of the American Society of Nephrology : JASN·James S KaufmanUNKNOWN Veterans Affairs Cooperative Study Group on Hemodialysis Access Graft Thrombosis
Nov 12, 2003·The American Journal of Cardiology·Srihari S NaiduRobert L Wilensky
Aug 9, 2006·Seminars in Dialysis·Dinkar Kaw, Deepak Malhotra
Sep 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Naoki IshioIssei Komuro
Dec 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Toru AoyamaToyoaki Murohara
Aug 30, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Takenori OkadaNobuoki Kohno
Mar 20, 2009·Journal of the American Society of Nephrology : JASN·Kevin E ChanRaymond M Hakim
Apr 28, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Sen YachiKazuhiro Hara
May 8, 2009·The New England Journal of Medicine·Stefan K JamesUNKNOWN SCAAR Study Group
Jun 3, 2009·The American Journal of Medicine·Henri RoukozDeepak L Bhatt
Jul 7, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Swapnil HiremathDeborah L Zimmerman
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Aug 13, 2009·Nephron. Clinical Practice·Michael A RosenblumMichael C Kim
Apr 10, 2010·International Heart Journal·Eiji IchimotoIssei Komuro
May 28, 2010·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ahmed Abdel-LatifKhaled M Ziada
Dec 28, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·David M CharytanLaura Mauri
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Mar 16, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Yu MiaoJia De-An
Apr 10, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·Hideki IshiiToyoaki Murohara
Nov 20, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Dong-Yi ChenTien-Hsing Chen
Mar 26, 2016·Journal of the American College of Cardiology·Tara I ChangWolfgang C Winkelmayer
Feb 22, 2017·The American Journal of Cardiology·Shan LiWeiwei Xu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.